Bone Marrow Donation: Registry, Procedures, and Ethics
This paper examines bone marrow donation and the role of Be the Match, the National Bone Marrow Donor Program's registry, in matching donors with recipients. It traces the history of bone marrow transplantation, distinguishes between autologous and allogenic transplants, and catalogs the wide range of diseases treatable by transplant. The paper also describes both peripheral blood stem cell and traditional marrow donation procedures, discusses the risk of Graft vs. Host Disease, and highlights racial disparities in donor registry participation. Finally, it addresses the legal and ethical debate over compensating bone marrow donors, concluding that the current volunteer-only system creates critical shortages that make broader registration essential.
- Introduction to Be the Match and Bone Marrow Donation: Overview of the national donor registry and its mission
- History and Types of Bone Marrow Transplants: Historical development and autologous vs. allogenic transplants
- Diseases Treatable by Bone Marrow Transplant: Cancers, blood disorders, and immune diseases addressed by transplant
- The Donation Process: Procedures and Risks: PBSC and traditional marrow donation steps and side effects
- Graft vs. Host Disease and Transplant Complications: Acute and chronic rejection risks and mitigation strategies
- Racial Disparities in Donor Registration: Minority underrepresentation and the Daniel De-Gale case
- The Ethics and Legal Debate Over Donor Compensation: Legal challenges and arguments for and against paying donors
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper moves logically from background and history through medical detail and finally to ethical controversy, giving the reader a complete picture of the topic before arriving at its advocacy conclusion.
- It supports factual claims with a mix of medical literature (Clark & Craddock, Armitage) and journalism (Park, Neergaard), demonstrating range across source types.
- The Daniel De-Gale case study grounds the abstract statistics about minority donor shortages in a concrete, humanizing narrative, strengthening the paper's persuasive appeal.
Key academic technique demonstrated
The paper uses the expository-to-argumentative progression effectively: it first establishes shared factual ground (medical procedures, diseases, statistics) and only then introduces the contested ethical and legal debates. This sequencing builds credibility before advocacy, a technique well suited to health policy writing.
Structure breakdown
The paper opens by introducing Be the Match and its mission, then provides historical context for transplantation. It catalogues treatable diseases, explains both donation procedures in detail, and addresses rejection risks. It then shifts to social equity (racial disparities) and concludes with the legal dispute over donor compensation. A brief conclusion restates the call to register as a donor.
Introduction to Be the Match and Bone Marrow Donation
Be the Match is the central bone marrow donation registry for the United States, operated by the National Bone Marrow Donor Program. Through the organization's website and outreach programs, people can register to become potential bone marrow donors. Be the Match is a non-profit organization that works with doctors, patients, and donors to help match recipients. It does not provide compensation to donors and does not require payment from patients in order to provide matches. Becoming a potential donor registered with Be the Match is a straightforward process that requires little initial commitment, though any person signing up as a potential donor should be prepared for a high level of commitment if chosen as a match for a patient.
History and Types of Bone Marrow Transplants
Bone marrow transplants can be used to treat a variety of different medical conditions, and the concept of marrow donation has been around for well over 100 years. For example, in the late 1800s, patients received bone marrow orally in order to treat blood disorders (Armitage, 1994). This oral use of bone marrow was not successful, but it did reveal a growing awareness that marrow could be used to help treat blood and marrow disorders. This scientific knowledge grew so that, as early as the 1930s, doctors were beginning to experiment with the injection of bone marrow from donors into recipients. The field has expanded greatly in the last few decades, with bone marrow transplants offering significant medical options to people with a variety of diseases.
When discussing bone marrow donation, it is important to recognize that there are two broad types of bone marrow transplants: autologous and allogenic. Autologous transplants are those in which a patient donates marrow to himself or herself, and therefore do not require an outside donor. These types of transplants have been successful in the treatment of lymphoma (Armitage, 1994). Allogenic transplants, by contrast, occur when one person donates bone marrow to another person. Several sources of stem cells can be used in allogenic transplants: a synegenic donor refers to an identical twin; other sources include human leucocyte antigen (HLA) matched siblings or family members, HLA-matched unrelated donors, HLA antigen-mismatched donors, haploidentical donors (HLA haplotype matched), and umbilical cord blood donors (Clark & Craddock, 2007).
While siblings provide the best opportunity for a bone marrow match, the reality is that most people in need of allogenic marrow donations do not have a sibling who will match them. Therefore, bone marrow registries are a critically important mechanism for matching recipients with suitable donors.
Diseases Treatable by Bone Marrow Transplant
Bone marrow donations can be used to treat a variety of diseases and, in some circumstances, may offer the only cure for patients with certain conditions. Several types of leukemias and lymphomas are treatable by bone marrow transplant and can even be cured by the procedure (National Marrow Donor Program, 2013, Diseases). Transplants can also be used to treat a variety of bone marrow and blood-related diseases, including severe aplastic anemia, Fanconi anemia, paroxysmal nocturnal hemoglobinuria, pure red cell aplasia, and amegakaryocytosis/congenital thrombocytopenia (National Marrow Donor Program, 2013, Diseases).
Bone marrow transplants may also be used to combat inherited immune system disorders such as all types of severe combined immunodeficiency (SCID) and Wiskott-Aldrich syndrome (National Marrow Donor Program, 2013, Diseases). They may further treat diseases that affect red blood cell function (hemoglobinopathies), such as beta thalassemia major, sickle cell disease, Krabbe disease (GLD), Hurler syndrome, adrenoleukodystrophy (ALD), metachromatic leukodystrophy (MLD), myelodysplastic syndromes, and myeloproliferative disorders (National Marrow Donor Program, 2013, Diseases). Bone marrow transplants have additionally been used to treat multiple myeloma, plasma cell disorder, familial erythrophagocytic lymphohistiocytosis and other histiocytic disorders, and other cancers and malignancies (National Marrow Donor Program, 2013, Diseases).
In many instances, patients and family members face a difficult situation: knowing that a bone marrow transplant is needed but having no available matched donor. This reality has led individuals to actively educate others about bone marrow donation and to urge people to sign up and be tested for the registry (Attwood, 2004). Be the Match and the National Marrow Donor Program aim to reduce the likelihood that a person who could be saved by a bone marrow donation will die due to a lack of an available matched donor.
References
Armitage, J. O. (1994). Bone marrow transplantation. The New England Journal of Medicine, 330(12), 827–38.
Attwood, K. (2004). Plea for marrow donors: First edition. The Independent, 22. Print.
Bone marrow wait over: Final edition. (1999). The Independent, 5. Print.
Clark, F., & Craddock, C. (2007). Chapter 12: Stem cell transplantation. In D. Povan (Ed.), ABC of clinical haematology (3rd ed., pp. 67–71). Malden, MA: Blackwell Publishing Ltd.
McCaffrey, J., & Walsh, J. (2008). Daniel helped us beat the odds; Exclusive brave victim who gave black cancer patients hope. The Mirror. Retrieved November 29, 2013, from
National Marrow Donor Program. (2013). Diseases treatable by transplants. Retrieved November 26, 2013, from Be the Match website:
National Marrow Donor Program. (2013). FAQs about joining. Retrieved November 26, 2013, from Be the Match website: http://bethematch.org/Support-the-Cause/Donate-bone-marrow/Join-the-marrow-registry/FAQs-about-joining/
National Marrow Donor Program. (2013). How bone marrow transplants work. Retrieved November 26, 2013, from Be the Match website:
Neergaard, L. (2013, November 17). Gov't to keep ban on paying bone marrow donors. Retrieved November 28, 2013, from ABC News website:
Park, A. (2012, July 2). A court allows payment for bone marrow. Should people be able to sell their parts? Retrieved November 28, 2013, from Time Magazine website:
Rubin, R. (2010). A bone marrow price tag?: Lawsuit argues that lives would be saved if donors were compensated. USA Today, B.7. Print.
Create your account
Always verify citation format against your institution’s current style guide requirements.